| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.004 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.099 | 0.006 |